Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    CAS 86087-24-3 manufacturers and suppliers on PharmaCompass

    Client Email Product

    CAS 86087-24-3

    Manufacturers/Suppliers

    PharmaCompass
    CAS 86087-24-3
    Also known as: 86087-24-3, (r)-tetrahydrofuran-3-ol, (3r)-oxolan-3-ol, (r)-3-hydroxytetrahydrofuran, (3r)-tetrahydrofuran-3-ol, 3-furanol, tetrahydro-, (3r)-
    Molecular Formula
    C4H8O2
    Molecular Weight
    88.11  g/mol
    InChI Key
    XDPCNPCKDGQBAN-SCSAIBSYSA-N
    1 2D Structure

    CAS 86087-24-3

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3R)-oxolan-3-ol
    2.1.2 InChI
    InChI=1S/C4H8O2/c5-4-1-2-6-3-4/h4-5H,1-3H2/t4-/m1/s1
    2.1.3 InChI Key
    XDPCNPCKDGQBAN-SCSAIBSYSA-N
    2.1.4 Canonical SMILES
    C1COCC1O
    2.1.5 Isomeric SMILES
    C1COC[C@@H]1O
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. 86087-24-3

    2. (r)-tetrahydrofuran-3-ol

    3. (3r)-oxolan-3-ol

    4. (r)-3-hydroxytetrahydrofuran

    5. (3r)-tetrahydrofuran-3-ol

    6. 3-furanol, Tetrahydro-, (3r)-

    7. (r)-(+)-3-hydroxytetrahydrofuran

    8. (r)-tetrahydro-furan-3-ol

    9. (r)-(-)-tetrahydrofuran-3-ol

    10. 84976-47-6

    11. Mfcd00067101

    12. Tetrahydrofuran-3alpha-ol

    13. (3r)-tetrahydro-3-furanol

    14. (r)-3-hydroxy-tetrahydrofuran

    15. (-)-(r)-3-hydroxytetrahydrofuran

    16. Act10453

    17. Zinc4716349

    18. (3r)-(-)-3-hydroxytetrahydrofuran

    19. (r)-(-)-3-hydroxy Tetrahydrofuran

    20. (r)-(-)-3-hydroxy-tetrahydrofuran

    21. Bbl100951

    22. Stl554745

    23. Akos005256250

    24. Ps-9390

    25. Wt81753

    26. (r)-(-)-tetrahydro-3-furanol

    27. Ac-13894

    28. (r)-(-)-3-hydroxytetrahydrofuran, 98%

    29. Am20110237

    30. Cs-0045411

    31. H1332

    32. 087h243

    2.3 Create Date
    2006-01-25
    3 Chemical and Physical Properties
    Molecular Weight 88.11 g/mol
    Molecular Formula C4H8O2
    XLogP3-0.4
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count0
    Exact Mass88.052429494 g/mol
    Monoisotopic Mass88.052429494 g/mol
    Topological Polar Surface Area29.5 Ų
    Heavy Atom Count6
    Formal Charge0
    Complexity44.8
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    ListList of Suppliers
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    Cangzhou Senary Chemical Science-te...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      2.3.4.6- Tetrakis-O-trimethylsilyl-D-gluconolactone

      PDF Supplier PDF
      URL Supplier Web Content
      32384-65-9
      Empagliflozin
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Cangzhou Senary Chemical Science-te...

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        4-((5-bromo-2-chlorophenyl)methyl)phenol

        PDF Supplier PDF
        URL Supplier Web Content
        864070-18-8
        Empagliflozin
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        Cangzhou Senary Chemical Science-te...

        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          (3S)-3[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrah...

          PDF Supplier PDF
          URL Supplier Web Content
          915095-89-5
          Empagliflozin
          Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
          Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content
          Ask Us for Pharmaceutical Supplier and Partner
          Ask Us, Find A Supplier / Partner
          No Commissions, No Strings Attached, Get Connected for FREE

          What are you looking for?

          How can we help you?

          The request can't be empty

          Please read our Privacy Policy carefully

          You must agree to the privacy policy

          The name can't be empty
          The company can't be empty.
          The email can't be empty Please enter a valid email.
          The mobile can't be empty
          famar-2024-07-22

          Access Virtual Booth

          Contact Supplier

          View Presentation

          Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

          Access Virtual Booth

          Contact Supplier

          View Presentation

          Post Enquiry
          POST ENQUIRY

          Market Place

          Market Place

          PharmaCompass

          Home

          Market Place

          Menu

          Post Enquiry

          Post Enquiry

          Market Place

          Market Place

          Search